Avalo Therapeutics, Inc. (AVTX)
Pharmaceutical Preparations
Latest Price
$16.18
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
14.06
P/B Ratio
1.15
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 5.10M | $94.0M | 9.64% | +2.22M | 2026-06-30 |
| BlackRock, Inc. | 4.37M | $80.0M | 8.25% | +4.04M | 2026-06-30 |
| Deep Track Capital, LP | 3.61M | $66.0M | 6.82% | +3.47M | 2026-06-30 |
| Caligan Partners LP | 3.16M | $58.0M | 5.98% | +1.53M | 2026-06-30 |
| TCG Crossover Management, LLC | 3.02M | $55.0M | 5.70% | +2.28M | 2026-06-30 |
| STATE STREET CORP | 2.89M | $53.0M | 5.46% | +2.82M | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 2.50M | $46.0M | 4.72% | -- | 2026-06-30 |
| Point72 Asset Management, L.P. | 2.39M | $44.0M | 4.51% | +1.47M | 2026-06-30 |
| Avoro Capital Advisors LLC | 2.33M | $43.0M | 4.41% | +923.3K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.26M | $41.0M | 4.28% | +1.54M | 2026-06-30 |